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Effects of duodenal switch alone or in combination with sleeve
gastrectomy on body weight and lipid metabolism in rats
OA Gudbrandsen1,2, Y Kodama3, SA Mjøs4,5, C-M Zhao3, H Johannessen3, H-R Brattbakk2, C Haugen2,6,7, B Kulseng3,8, G Mellgren2,6,7
and D Chen3,8
BACKGROUND: A combined procedure of sleeve gastrectomy and duodenal switch (SGþDS) has been applied to the treatment of
super obesity. The aim of the present study was to test whether duodenal switch alone (DS) leads to similar weight loss and
changes in lipid metabolism as SGþDS.
METHODS: Male Sprague–Dawley rats underwent sham surgery (Sham, N¼ 7), duodenal switch alone (DS, N¼ 5) or sleeve
gastrectomy followed by duodenal switch (SGþDS, N¼ 5). Body weight, feed and water intakes, and ambulatory activity were
recorded 2 months post surgery. Tissue and faecal lipids, faecal bile acids, plasma cytokines and lipid metabolism-related gene
expression in adipose tissue and liver were analysed.
RESULTS: Daily energy intake, relative feed uptake, ambulatory activity and body weight reduction were similar between DS and
SGþDS rats. The hepatic triacylglycerol content was higher and faecal secretion of triacylglycerol was lower after SGþDS
compared to DS (Po0.05). Faecal bile acid secretion was higher in SGþDS than in DS rats (Po0.05) despite similar hepatic
CYP7A1mRNA level. Plasma levels of proinﬂammatory cytokines interleukin (IL)-1b, IL-2, IL-4, IL-5, IL-6, IL-12, granulocyte-
macrophage colony stimulating factor and tumour necrosis factor alpha were higher in SGþDS than in DS rats (Po0.05).
CONCLUSIONS: Although DS and SGþDS had similar efﬁcacy in terms of body weight loss, SGþDS resulted in a poorer regulation
of lipid metabolism than DS.
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INTRODUCTION
The prevalence of obesity has reached epidemic proportions and
is one of the leading public health concerns on a worldwide
scale.1 Obesity causes or exacerbates many health problems, and
is associated with the development of diseases such as coronary
heart disease, mediated through disturbances of lipid metabolism
and blood pressure.2
Strategies for weight loss include reduced energy intake from
foods, increased physical activity, medical treatment and bariatric
surgery. For individuals with severe obesity (body mass index
440 kgm 2), dietary therapy, even together with exercise and
behaviour therapy, is rarely successful,3 and most medical or
behavioural interventions result in only 5–10 percentage excess
weight loss.4 The most effective and recognized method for
treating morbid obesity is bariatric surgery.5–7
Bariatric surgery is believed to reduce the nutrient uptake,
either by restricting the energy intake by procedures such as
sleeve gastrectomy (SG) that reduces the volume of the stomach
and thus the amount of food eaten, or by reducing the uptake
from the intestinal tract after bypassing parts of the small intestine
by procedures such as duodenal switch (DS), or a combination of
restrictive and malabsorptive elements such as sleeve gastrect-
omy and duodenal switch (SGþDS) or gastric bypass (GB). Very
recently, this dogma has been challenged by an animal study in
which SG surgery was applied to mice.8 The study points to
bile acids and farsenoid-X receptor signalling as an important
molecular underpinning for the beneﬁcial effects of this weight-
loss surgery.
GB is the most common procedure because of its relatively high
efﬁcacy and safety, whereas the combination of SG and DS
(SGþDS) has been shown to be even more effective than GB,
particularly in super-obese patients in terms of body weight loss9
as well as improvement of comorbidities such as diabetes,
hypertension and dyslipidemia.10–12 Recently, we have reported
that GB induced body weight loss mainly by increasing energy
expenditure, whereas SGþDS induced greater body weight loss
by reducing food intake, increasing energy expenditure and
causing malabsorption in rat models.13
Previously, we have shown that DS without SG could be an
independent bariatric procedure for inducing weight loss in rats.14
Later, a study showed that SG (without DS) led to a marked,
weight-independent reduction in secretion of intestinal
triglycerides, and suggested that SG has important effects on
lipid metabolism.15 Thus, in the present study we wanted to test
our hypothesis that the combination of SGþDS exhibits beneﬁcial
effects not only in body weight loss but also in lipid metabolism
by using rat models of surgery.
MATERIALS AND METHODS
Animals and diets
Male Sprague–Dawley rats (Taconic M&B, Skensved, Denmark)
aged 3 months were housed at a 12-h light–dark cycle, 221C and
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40–60% humidity. All rats had free access to tap water and feed (RM1,
Special Diets Services, Witham, UK).
Experimental design
Rats aged 3 months were divided into three experimental groups:
duodenal switch alone (DS, N¼ 7), sleeve gastrectomy followed by
duodenal switch (SGþDS, N¼ 6) and sham operation (controls, N¼ 7).
Sample sizes were kept small in consideration of the ‘3Rs’ for the humane
use of animals (for example, reduction of animal numbers to the minimum
consistent with achieving the scientiﬁc purposes of the experiment).16
DS, SG and sham surgery were performed when the rats’ average body
weight was 525 g, and DS following SG was performed 3 months after SG.
The numbers of surviving rats in the experimental groups were 5 DS rats,
5 SGþDS rats and 7 sham rats. The rats were euthanized 2 months after
their last surgical procedure, while they were under anaesthesia with 2–4%
Isoﬂuran (Baxter Medical AB, Kista, Sweden) mixed with nitrous oxide and
oxygen. It cannot be excluded that the difference in age at the time of
sacriﬁce may make it difﬁcult to dissociate procedure from ageing effects.
However, based on our previous study of 1-year follow-up after bariatric
surgery (for example, GB), there would unlikely be big differences within a
window of 3–6 months.17
Blood was drawn from the abdominal aorta and EDTA added. Liver,
skeletal muscle from the thigh and epididymal white adipose tissue were
instantly removed and frozen in liquid nitrogen.
The experimental protocol was approved by the Norwegian Animal
Research Authority.
Surgery
Surgeries were performed under general anaesthesia (Isoﬂuran, Baxter
Medical AB). SG was performed by resecting 75% of the glandular stomach
along the greater curvature. DS was constructed by transecting the
duodenum 1 cm to the pylorus, and a common channel was created by
dividing the ileum 5 cm proximal to the ileocaecal junction. The distal limb
of the ileum was anastomosed to the post-pyloric duodenum in an end-
to-end manner, and the stump of the duodenum was closed with cross-
suture. The distal anastomosis was performed by joining the distal
biliopancreatic limb at 1 cm to the ileocaecal junction in an end-to-side
manner.
Eating and metabolic parameters
Rats were placed in the cages for a comprehensive laboratory animal
monitoring system (CLAMS; Columbus Instruments International, Columbus,
OH, USA) for registration of feed and water intake, registration of ambulatory
activity and collection of faeces for 48 h with free access to standard rat
powder feed (RM1) and tap water.
Lipids in tissues and faeces
Lipids were extracted from the liver, skeletal muscle and faeces by the
method of Bligh and Dyer,18 evaporated under nitrogen and re-dissolved
in isopropanol before analysis on Cobas c111 system (Roche Diagnostics
GmbH, Mannheim, Germany) using the appropriate kits from Roche
Diagnostics GmbH.
Total faecal bile acids
Faecal total bile acids (3a-hydroxy bile acids) were measured in freeze-
dried faeces,19 using Chromabond C18ec (3ml/200mg, Macherey-Nagel,
Du¨ren, Germany) and the enzymatic bile acid kit from Sigma Diagnostics
(St Louis, MO, USA) on the Cobas c111 system.
Fatty acids in liver and skeletal muscle
Lipids were extracted from liver and muscle samples using a mixture of
chloroform and methanol.18 Heneicosanoic acid was added to the extracts
as internal standard. The extracts were methylated as described
previously20 and extracted twice with isooctane. The methyl esters were
quantiﬁed by an 7890 gas chromatograph (Agilent, Santa-Clara, CA, USA)
equipped with a ﬂame ionization detector and a BPX-70 capillary column
as described in Sciotto and Mjos21 with minor adjustments of the
temperature programme. The compounds were identiﬁed by gas
chromatography–mass spectrometry using the BPX-70 column and
methodology as described in Wasta and Mjos.22
qRT-PCR
Total RNA was puriﬁed from epididymal white adipose tissue and liver
using the RNeasy Lipid Tissue Midi Kit for adipose tissue and the RNeasy
Mini Kit for liver samples (Qiagen, Hilden, Germany). qRT-PCR was carried
out in triplicate using the LightCycler480 instrument, Probes Master kit and
the LightCycler480 rapid thermal cycler system (Roche Diagnostics GmbH),
and complementary DNA was ampliﬁed using target-speciﬁc primers and
Universal ProbeLibrary (UPL) probes (Roche Diagnostics GmbH). The
following primers and UPL probes were used: low-density lipoprotein
receptor (LDLr, UPL #16), acetyl-CoA carboxylase (Acaca, UPL #63), sterol
O-acyltransferase (Soat2, UPL #75), cholesterol 7 alpha-hydroxylase
(Cyp7a1, UPL #110), HMG-CoA reductase (Hmgcr, UPL #122), glucose
transporter GLUT2 (Slc2a2, UPL #122), glucose transporter GLUT4 (Slc2a4,
UPL #67), 18S rRNA (Mrps18a, UPL #117), acidic ribosomal phosphoprotein
P0 (Arbp, UPL #85) and ribosomal protein L32 (Rpl32, UPL #117). Of the
three reference genes tested (Arbp, Mrps18a and Rpl32), Mrps18 was least
affected by surgical interventions; therefore results are shown relative to
Mrps18a and normalized to controls.
Plasma levels of cytokines
Cytokines in plasma were analyzed using a multiplex cytokine assay (Cat no.:
171-K1002M, Bio-plex Pro Rat Cytokine Th1/Th2 12-plex Panel; Bio-Rad
Laboratories, Hercules, CA, USA) for interleukin (IL)-1a, IL-1b, IL-2, IL-4, IL-5, IL-6,
IL-10, IL-12, IL-13, granulocyte-macrophage colony stimulating factor, inter-
feron gamma and tumour necrosis factor alpha. The analysis was performed
on a Luminex 100/200TM System (Luminex Corp., Austin, TX, USA)
Statistical analysis
One-way ANOVA followed by a Tukey post hoc test was applied where
appropriate for comparison between the experimental groups (PASW 19.0
software, IBM Corporation, Armonk, NY, USA). Principal component analysis
and soft independent modelling of class analogies of the fatty acid results
were performed using Unscrambler 9.8 (CAMO, Oslo, Norway). Prior to
extraction of the principal components the data were normalized so that
the fatty acids for each object summarized to 100%, and variables were
divided by their own standard deviation (standardization) before the mean
values were subtracted (centering). P values o0.05 were considered
statistically signiﬁcant.
RESULTS
Bodyweight, growth, energy and water intake
The body weight was similar between all experimental groups at
the time of the ﬁrst surgery (Table 1). Twelve weeks after sleeve
gastrectomy, the rats in the SGþDS group underwent duodenal
switch, and no signiﬁcant change was seen in body weight at the
time of the second surgery. The body weight was similar between
the DS and SGþDS groups at the time of euthanasia, and for both
groups the average body weight was signiﬁcantly lower compared
to sham-operated rats (P¼ 3 10 7 and 7 10 7, respectively).
Concomitantly, the weight loss after surgery was similar between
DS and SGþDS groups. The daily energy intake was similar
between DS and SGþDS, whereas the water intake was lower in
SGþDS rats than in DS rats (P¼ 0.03). Both the daily energy and
water intake were signiﬁcantly lower in DS and SGþDS rats when
compared to sham rats (Po0.001). The energy intake relative to
body weight was similar between DS and SGþDS, but was
signiﬁcantly higher in DS when compared to sham rats (P¼ 0.01).
The water intake relative to body weight was signiﬁcantly lower in
SGþDS when compared to DS rats (P¼ 0.006). The ambulatory
activity was similar between all groups, both considering total
counts per day and counts relative to energy intake.
Levels of triacylglycerol and cholesterol in the liver and skeletal
muscle
The hepatic triacylglycerol content was signiﬁcantly higher
(P¼ 0.002) and the hepatic cholesterol content tended to be
higher (P¼ 0.068) in SGþDS when compared to DS (Table 2). The
liver samples collected were frozen directly and were not
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chemically ﬁxated for histological use, but Sudan black staining
supported a higher lipid content in SGþDS rats (data not shown).
In muscle, no differences were seen in triacylglycerol and
cholesterol content between DS and SGþDS. When compared to
Sham rats, the triacylglycerol content was signiﬁcantly lower and
the cholesterol content was signiﬁcantly higher in muscle after
SGþDS (P¼ 0.02 for both comparisons).
Fatty acid composition in liver and muscle
The principal component analysis bi-plots of the fatty acid
compositions in Figure 1 give an overview of the group
differences in liver and muscle. In both liver and muscle the
objects are separated into three distinct classes based on
differences in fatty acid composition, but there is limited
separation between DS and SGþDS. In liver (Figure 1a) DS is
separated from the sham group along the ﬁrst principal
component (PC1), which explains 46% of the variance in the
data, while DSþ SG is separated from the sham group basically
along PC2, which explains 24%. Thus, DS is more different from
sham-operated rats. The plot of the muscle fatty acids (Figure 1b)
shows the same trend as seen in liver, as sham rats are separated
from DS and SGþDS rats basically by PC1 (53%) while the two
operated groups are separated by PC2 (22%). Some trends in the
fatty acid composition were seen in both liver and muscle, for
instance that C18:2n-6, C14:0, C18:3n-3, C16:1n-7, C16:0 and
C20:5n-3 were in the direction of the sham group. In both tissues,
the long-chain n-6 PUFAs C22:4n-6 and C22:5n-6 were positioned
in opposite directions from the sham group, indicating lower
amounts in this group. The clearest effect of the surgeries on a
single fatty acid was seen on C22:5n-6, which was much lower in
all sham rats. Analysis by the soft independent modelling of class
analogies showed that all DS and SGþDS rats were signiﬁcantly
different from sham at a 5% level in both liver and muscle.
The hepatic levels of total saturated fatty acids (SFA), C14:0,
C15:0 and C17:0 were similar between DS and SGþDS rats,
whereas the level of C16:0 was higher and that of the longer SFAs,
C18:0, C20:0, C22:0, C23:0 and C24:0, were lower in SGþDS when
compared to DS (Po0.05, Table 3). The total MUFA amount in liver
was signiﬁcantly higher in SGþDS when compared to DS
(P¼ 0.03), mainly due to higher level of C18:1n-9 in the SGþDS
rats (P¼ 0.02). The hepatic Sn-3 PUFA level was signiﬁcantly lower
in SGþDS when compared to DS rats (P¼ 0.04), due to a high
level of C22:6n-3 in SGþDS rats (P¼ 0.01). In SGþDS rats the
hepatic levels of C18:3n-6 and C22:4n-6 were higher and that of
C20:4n-6 was lower when compared to DS (Po0.05), with no
differences in total n-6 PUFA level between these groups. The ratio
of C18:1n-9 to C18:0 was signiﬁcantly higher in SGþDS compared
to DS (P¼ 0.03), implying that the activity of stearoyl-CoA
desaturase was higher in the liver from SGþDS rats. The ratio
of C20:4n-6 to C18:2n-6 was lower in the liver from SGþDS rats
when compared to DS (P¼ 0.04), implying a lower activity in
delta-6 and/or delta-5 desaturases in SGþDS rats.
In skeletal muscle, the amounts of C15:0 and C17:0 were
signiﬁcantly lower in SGþDS compared to DS (Po0.05), and no
differences were seen between these groups regarding total SFA
(Table 3). Also, SMUFA was similar between muscle from DS and
SGþDS, albeit the amount of C18:1n-7 was signiﬁcantly higher in
GSþDS rats (P¼ 0.008). The total amount of n-3 PUFA and the
level of the individual n-3 PUFAs were similar between DS and
SGþDS rats. The total n-6 PUFA was signiﬁcantly higher in GSþ
DS rats when compared to DS (P¼ 0.001), although the amount of
Table 2. Levels of triacylglycerol and cholesterol in liver and skeletal muscle, and faecal mass, relative feed uptake and faecal secretion of
triacylglycerol, cholesterol and total bile acids in faeces
Sham (N¼ 6) Duodenal switch (N¼ 5) Sleeve gastrectomyþ duodenal switch (N¼ 5)
Liver triacylglycerols, mmol per g liver 12.1±3.7a,b 4.4±2.4a 19.2±8.2b
Liver total cholesterol, mmol per g liver 5.6±0.6 5.0±0.5 6.1±0.9
Muscle triacylglycerols, mmol per g muscle 7.6±3.9a 3.7±2.6a,b 2.2±1.1b
Muscle total cholesterol, mmol per g muscle 1.6±0.2a 2.5±0.7a,b 2.9±1.1b
Faeces, g per 24 h 4.6±1.1 5.9±0.7 4.1±1.4
Faeces, g dry material per 24 h 3.3±0.7 4.1±0.5 3.1±0.9
Relative feed uptake (dry feed/dry faecal weight)1 5.1±0.7a 2.4±0.3b 2.9±0.7b
Faecal triacylglycerol, mmol per 24 h 6.2±3.4a,b 13.5±6.9a 4.3±4.0b
Faecal total cholesterol, mmol per 24 h 18.8±7.2 25.9±9.8 14.0±5.2
Faecal total bile acids, mmol per 24 h 34.0±16.5a 12.3±7.6b 35.9±10.8a
Results are presented as means±s.d. Means between groups were tested with one-way ANOVA using Tukey post hoc test. Means in a row with different letters
are significantly different (Po0.05). 1Moisture content in feed was 10%.
Table 1. Bodyweight at times of surgeries and euthanasia, growth, daily energy and water intake, and ambulatory activity at 8 weeks after surgery
Sham (N¼ 7) Duodenal switch (N¼ 5) Sleeve gastrectomyþ duodenal switch (N¼ 5)
Body weight at time of first surgery, g 570±70 529±40 549±66
Body weight at time of second surgery, g No surgery No surgery 537±44
Body weight at time of euthanasia, g 589±77a 257±39b 276±37b
Weight change, percent 3±5a  52±5b  48±7b
Energy intake,1 kJ per 24 h 217±33a 132±13b 117±25b
Energy intake, kJ per kg BW 356±66a 496±44b 407±90a,b
Water intake, ml per 24 h 14.3±2.1a 7.9±2.9b 4.1±1.4c
Water intake, ml per kg BW 23±4a,b 30±10a 14±6b
Ambulatory activity, counts per 24 h 5784±1808 2934±1844 4133±2075
Ambulatory activity, counts per kJ energy intake 28±11 22±14 33±14
Results are presented as means±s.d. Means between groups were tested with one-way ANOVA using Tukey post hoc test. Means in a row with different letters
are significantly different (Po0.05). 1Digestable energy 11.90 MJ per kg feed (2.47% digestible oils, 12.92% digestible protein and 4.05% sugar).
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C18:2n-6 was signiﬁcantly lower in the GSþDS rats (P¼ 0.02).
The ratios C18:1n-9/C18:0 and C20:4n-6/C18:2n-6 were similar
between muscles from DS and SGþDS rats.
Faecal output
No signiﬁcant differences was seen in the total faecal mass
or the dry faecal mass between the experimental groups
(Table 2), but there was a tendency for a higher faecal mass in
DS when compared to SGþDS (P¼ 0.054). The relative feed
uptake (moisture free feed intake/dry faecal material output) was
similar between DS and SGþDS rats, and was signiﬁcantly lower
in both DS and SGþDS rats when compared to sham rats
(P¼ 1 10 5 and 8 10 5, respectively). The daily faecal
triacylglycerol output was signiﬁcantly higher in DS when
compared to SGþDS (P¼ 0.02), and tended to be higher when
compared to sham rats (P¼ 0.052). No signiﬁcant differences
were seen between the experimental groups regarding daily
faecal cholesterol output; however, there was a tendency for a
higher output in DS when compared to SGþDS (P¼ 0.062). The
daily faecal output of total bile acids was signiﬁcantly lower in DS
when compared to SGþDS and sham rats (P¼ 0.03 for both
comparisons).
Expression of genes in WAT and liver
The mRNA level of acetyl-CoA carboxylase-a (Acaca) in white
adipose tissue was similar between DS and SGþDS rats, and was
signiﬁcantly lower in DS (P¼ 0.003) and tended to be lower in
SGþDS (P¼ 0.083) when compared to sham rats (Table 4),
suggesting that the endogenous fatty acid synthesis could be
lower in fat tissue after bariatric surgery, especially after DS. Both
DS and SGþDS groups had similar mRNA levels of glucose
transporter-4 (Slc2a4) and of LDL receptor (LDLr) in WAT, and both
groups had lower mRNA levels of Slc2a4 (P¼ 0.0003 and 0.003,
respectively) and LDLr (P¼ 0.03 and 0.04, respectively) when
compared to Sham rats, implying a lower uptake of both glucose
and LDL in adipose tissue after bariatric surgery.
No differences were seen between the groups regarding
hepatic mRNA level of Acaca (Table 4). The hepatic mRNA levels
of HMG-CoA reductase and Soat2, controlling cholesterol
biosynthesis and the esteriﬁcation of cholesterol, respectively,
were similar between DS and SGþDS. The cholesterol meta-
bolism in liver seems to be affected by bariatric surgery, as hepatic
mRNA level HMG-CoA reductase was higher in SGþDS rats
(P¼ 0.04), and that of Soat2 was higher in both DS and SGþDS
rats when compared to sham rats (P¼ 0.0008 and 0.01,
Figure 1. Principal component scores and loadings of fatty acid profiles in liver (a) and muscle (b).
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respectively). However, neither CYP7A1 nor LDLr hepatic mRNA
levels, catalysing the production of bile acids from cholesterol and
the uptake of cholesterol from circulation, respectively, were
different between the DS, SGþDS and Sham rats. The mRNA level
of the glucose transporter-2 gene (Slc2a2) was similar between DS
and SGþDS rats, and was signiﬁcantly lower in both DS and
SGþDS groups when compared to sham rats (P¼ 0.01 and 0.02,
respectively).
Plasma cytokines
The plasma levels of the cytokines IL-1a, IL-2, IL-4 and IL-5 were
signiﬁcantly higher in SGþDS rats when compared to DS rats
(P¼ 0.04, 0.005, 0.04 and 0.03, respectively), whereas no
differences were seen between the groups regarding IL-1b, IL-10
and interferon gamma (Table 5). The plasma levels of IL-6, IL-12
p70, IL-13, granulocyte-macrophage colony stimulating factor and
tumour necrosis factor alpha were below the limit of detection for
DS rats only, and the plasma levels of these cytokines were similar
between SGþDS and sham groups.
DISCUSSION
The surgical procedure of SGþDS is one of the best choices for
inducing weight loss in super-obese patients. SG is getting
increasingly more popular as the sole procedure for weight loss
due to its efﬁciency of reducing excess weight, simplicity and the
low occurrence of complications such as staple line leak.23–27
The DS procedure was originally created as a surgical solution
for primary bile reﬂux gastritis and/or to decrease postoperative
symptoms after distal gastrectomy and gastroduodenostomy.28 In
patients, the operation usually consists of a 75% longitudinal
gastrectomy (the so-called sleeve gastrectomy), creation of an
Table 3. Fatty acid compositions in liver and skeletal muscle
g per 100 g FA Liver Skeletal muscle
Sham (N¼ 6) Duodenal
switch (N¼ 5)
Sleeve
gastrectomyþ duodenal
switch (N¼ 5)
Sham (N¼ 6) Duodenal
switch (N¼ 5)
Sleeve
gastrectomyþ duodenal
switch (N¼ 5)
C14:0 0.54±0.08a 0.31±0.09b 0.40±0.08b 0.92±0.33a 0.46±0.21b 0.41±0.17b
C15:0 0.22±0.01a 0.37±0.05b 0.28±0.12a,b 0.16±0.02a 0.23±0.05b 0.15±0.03a
C16:0 22.99±0.89a 19.81±0.87b 22.98±1.24a 24.40±1.63 21.76±2.13 24.00±1.32
C17:0 0.29±0.03a 0.69±0.15b 0.54±0.26a,b 0.26±0.04a 0.53±0.12b 0.37±0.07a
C18:0 10.96±1.02a 15.66±1.73b 10.60±2.30a 9.11±1.98a 12.06±2.82a,c 12.72±1.78b,c
C20:0 0.05±0.01a 0.10±0.02b 0.07±0.01a ND ND ND
C22:0 0.16±0.02a 0.38±0.11b 0.21±0.07a 0.07±0.01 0.21±0.15 0.18±0.05
C23:0 0.17±0.03a 0.25±0.04b 0.15±0.06a ND ND ND
C24:0 0.39±0.04a,b 0.56±0.16a 0.32±0.15b 0.09±0.04 0.32±0.30 0.25±0.11
C16:1n-9 0.30±0.03 0.26±0.03a 0.38±0.10b 0.27±0.05 0.33±0.09 0.23±0.07
C16:1n-7 3.42±0.81a 0.75±0.31b 1.52±0.83b 4.00±1.66a 1.06±0.60b 1.15±0.63b
C18:1n-9 8.82±0.90a 7.91±1.76a 14.77±5.37b 10.85±3.15 10.83±3.66 7.11±2.49
C18:1n-7 5.62±0.99a 3.27±0.79b 3.36±1.02b 3.55±0.25a,b 4.33±1.06a 2.66±0.72b
C18:3n-3 0.39±0.10a 0.16±0.07b 0.22±0.06b 0.60±0.24a 0.20±0.11b 0.22±0.17b
C20:5n-3 0.27±0.05a 0.12±0.09b,c 0.20±0.11a,c 0.09±0.01a 0.02±0.01b 0.03±0.01b
C22:5n-3 1.98±0.22 1.93±0.19 2.10±0.47 2.20±0.35 2.62±0.55 2.67±0.21
C22:6n-3 6.63±0.93a,b 8.62±2.61a 4.93±1.48b 9.84±2.20 8.34±1.90 8.35±1.39
C18:2n-6 17.08±1.36 14.72±1.93 15.55±2.12 21.29±2.59 17.23±3.25a 14.91±4.02b
C18:3n-6 0.16±0.04a 0.47±0.18a 1.01±0.42b ND ND ND
C20:3n-6 0.96±0.39 0.53±0.06 0.75±0.20 0.57±0.16 0.70±0.19 0.79±0.08
C20:4n-6 16.68±0.97a 18.78±1.10a 14.02±2.46b 9.30±1.82a 14.33±3.26a,c 18.85±4.27b,c
C22:4n-6 0.58±0.09a 1.28±0.42b 2.09±0.60c 0.28±0.07 0.47±0.15 0.51±0.25
C22:5n-6 0.25±0.09a 2.06±0.74b 2.50±1.02b 0.19±0.05a 0.67±0.17b 0.91±0.22b
SSFA 35.76±0.99 38.13±1.89 35.55±3.81 34.10±1.85a 35.10±2.24a,b 37.68±1.10b
SMUFA 18.79±1.79a,b 12.90±2.69a 20.76±6.70b 18.66±4.76a 16.54±5.18a,b 11.15±3.58b
Sn-3 PUFA 9.27±1.01a,b 10.83±2.64a 7.45±1.89b 12.73±2.26 11.17±2.33 11.28±1.35
Sn-6 PUFA 36.04±1.16 38.06±1.52 36.19±2.60 31.63±2.30a 33.39±0.46a 35.97±0.84b
C18:1n-9/C18:0 0.81±0.10a,b 0.52±0.15a 1.56±1.00b 1.30±0.60 0.98±0.50 0.58±0.25
C20:4n-6/C18:2n-6 0.98±0.10a,b 1.30±0.22a 0.93±0.29b 0.45±0.13a 0.89±0.39a,b 1.46±0.91b
Abbreviations: FA, fatty acid; ND; not determined. Results are presented as means±s.d. Means between groups were tested with one-way ANOVA using Tukey
post hoc test. Means in a row within the same organ with different letters are significantly different (Po0.05).
Table 4. Relative expression of genes in epididymal white adipose
tissue and liver
Sham
(N¼ 7)
Duodenal
switch
(N¼ 5)
Sleeve
gastrectomyþ duodenal
switch (N¼ 5)
White adipose tissue
Acaca 1.00±0.24a 0.49±0.04b 0.71±0.27a,b
Slc2a4 1.00±0.19a 0.42±0.03b 0.58±0.26b
LDLr 1.00±0.58a 0.27±0.23b 0.30±0.29b
Liver
Acaca 1.00±0.15 1.15±0.39 1.36±0.64
HMG-CoA reductase 1.00±0.44a 2.67±1.15a,b 2.98±1.92b
Soat2 1.00±0.18a 1.74±0.16b 1.51 ±0.37b
CYP7A1 1.00±0.33 1.30±0.80 1.53±0.60
LDLr 1.00±0.16 0.88±0.26 0.80±0.13
Slc2a2 1.00±0.07a 0.71±0.18b 0.71±0.19b
Abbreviations: Acaca, acetyl-CoA carboxylase; CYP7A1, cholesterol 7 alpha-
hydroxylase; LDLr, low-density lipoprotein receptor; Slc2a2, glucose
transporter GLUT2; Slc2a4, glucose transporter GLUT4; Soat2, sterol
O-acyltransferase. Results are shown relative to 18S rRNA and normalized
to Sham for each tissue, and are presented as means±s.d. Means between
groups were tested with one-way ANOVA using Tukey post hoc test. Means
in a row with different letters are significantly different (Po0.05).
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alimentary limb that isB50% of the total small bowel length (that
is, bypassing jejunum), a common channel length of 100 cm and
cholecystectomy.29 In the present study using rats, DS was
performed according to the rat anatomy. For instance, the rat
stomach consists of antrum, fundus (also called corpus) and
rumen (forestomach), while the human stomach is divided into
antrum, body and fundus. The rat jejunum represents almost 90%
of the small intestine, the human jejunum about 40%.30 Unlike
humans, rats are nonemetic (not vomiting) and have no
gallbladder. We show that in rats a similar weight loss was
achieved in DS and SGþDS rats independently of the SG
procedure as DS seems to be a determinant for the outcome in
body weight. Concomitant with the similar body weight reduction,
the energy intake and the ambulatory activity were similar
between DS and SGþDS rats, although lipid metabolism seems
to be differently affected after these bariatric procedures.
It was expected that DS should lead to a malabsorption whereas
the combination of SG and DS should both reduce energy intake
and lead to malabsorption. In the present study, the daily energy
intake was similar between DS and SGþDS rats, and it was
signiﬁcantly lower compared to sham-operated rats. The water
intake was also signiﬁcantly lower in DS and SGþDS rats when
compared to sham-operated rats. Although the faecal total output
and the faecal dry mass were similar between all groups, the low
relative feed uptake (feed intake/faecal output) in DS and SGþDS
rats suggests that both surgical procedures lead to malabsorption.
The storage and faecal secretion of lipids seem to be differently
regulated in DS and SGþDS rats, which is of interest as others
have shown that hepatic lipid storage is not affected by SG
alone.15 Whereas no signiﬁcant difference was seen in liver
triacylglycerol content between DS and sham rats, the hepatic
triacylglycerol level in SGþDS was markedly higher compared to
both groups, suggesting a poorer regulation of lipid metabolism
after SGþDS. No differences were seen in muscle triacylglycerol
content between DS and SGþDS. Also, the faecal output of
triacylglycerol was signiﬁcantly higher and the faecal bile acid
secretion was signiﬁcantly lower in DS when compared to
SGþDS, possibly explaining the reduced storage of
triacylglycerol in liver from DS rats when compared to SGþDS.
No differences were seen between DS and SGþDS for any of
the genes investigated in liver. The higher mRNA expressions
of HMG-CoA reductase and Soat2 in SGþDS livers compared
to sham-operated rats suggest an increased production of
cholesterol and cholesteryl esters for storage, but no difference
was seen in hepatic total cholesterol between the experimental
groups. Concomitant with this, the mRNA expression of LDL
receptor and CYP7A1 in liver was similar between all groups. In
addition, the mRNA expression of LDL receptor in WAT was
signiﬁcantly lower in SGþDS rats compared to sham-operated
rats, suggesting that the cholesterol uptake in WAT was markedly
lower in SGþDS rats. In SGþDS rats, the storage of cholesterol in
muscle was similar to DS but signiﬁcantly higher when compared
to sham-operated rats. The faecal excretion of both cholesterol
and bile acids in SGþDS rats was similar to sham-operated rats,
thus suggesting that there is a change towards enhanced storage
of cholesterol in skeletal muscle after SGþDS in rats. This further
supports the notion that the lipid metabolism is poorer after
SGþDS than after DS alone.
The mRNA expression of Acaca in WAT was similar between DS
and SGþDS. The lower Acaca WAT mRNA level in DS rats
compared to sham-operated rats suggests that the fatty acid
synthesis was lower in DS rats; however, the expression of Acaca
in WAT was similar between SGþDS and sham-operated rats. In
liver, the Acaca mRNA level was similar between all groups,
suggesting that the lower hepatic triacylglycerol level in DS
compared to SGþDS rats was not controlled through Acaca. The
high hepatic level of C18:1n-9 in SGþDS relative to DS
corresponds well with the higher triacylglycerol content in SGþ
DS, and the high ratio of C18:1n-9 to C18:0 suggests that stearoyl-
CoA desaturase was upregulated to promote increased storage of
neutral fat in the liver of SGþDS rats.
The low mRNA level of Slc2a4 (GLUT4) in WAT in DS and
SGþDS rats suggests that the capacity for uptake of glucose was
reduced in these rats after surgery. A similar trend was seen in
liver, with a signiﬁcantly lower mRNA level of Slc2a2 (GLUT2) in DS
and SGþDS rats, which is in line with reports of lower hepatic
Slc2a2 mRNA level in diabetic rats after DS.31 A decrease in the
uptake of glucose to WAT and liver may suggest a reduced
conversion of glucose to triacylglycerol for storage in these tissues
after DS alone or the combined SGþDS.
The principal component analysis of fatty acids in liver and
muscle reveals that DS rats were not positioned between SGþDS
and sham-operated rats as could be expected, indicating that
there are different mechanisms that lead to the separation based
on differences in fatty acid composition. The fatty acids in the
direction of the DS and DSþ SG rats are minor fatty acids, except
C18:0, C20:4n-6 and C22:6n-3, which are typically found in
membrane lipids.32 This observation may therefore reﬂect a
reduced proportion of other lipid classes in these groups relative
to the control. In liver, the ratio of C20:4n-6 to C18:2n-6 was
signiﬁcantly higher in DS compared to SGþDS, suggesting higher
activities of delta-5 and delta-6 desaturases in DS. Concomitant with
this, the triacylglycerol content was signiﬁcantly lower in DS. The
ﬁnding of possible lower delta-5 and delta-6 desaturase activities
and higher amounts of triacylglycerol in the liver from SGþDS rats
is in line with ﬁndings by others that the activities of these
desaturases are low in obese non-alcoholic fatty liver patients.33
To see whether the poor lipid metabolism after SGþDS was
accompanied with adverse changes in inﬂammatory markers, a
panel of cytokines was analysed in plasma samples. Based on our
results, it seems that the inﬂammatory status was worse after
SGþDS than after DS alone, since the plasma levels of the
proinﬂammatory cytokines IL-1a, IL-2, IL-4, IL-5, IL-6, IL-12,
granulocyte-macrophage colony stimulating factor and tumour
necrosis factor alpha were higher in the SGþDS group than in the
DS group. Thus, our results show that the adverse effects on lipid
metabolism after SGþDS compared to DS alone are accompanied
with a worsening of the inﬂammatory status in SGþDS rats.
Taken together, our results suggest that DS (without additional
SG) may be considered as a sole surgical procedure for obesity
treatment. Although SG followed by DS led to similar weight
Table 5. Plasma levels of cytokines
pg ml 1 Sham
(N¼ 3)
Duodenal
switch (N¼ 5)
Sleeve
gastrectomyþ duodenal
switch (N¼ 5)
IL-1a1 94±58a,b 31±21a 125±19b
IL-1b 310±303 29±18 215±196
IL-2 190±69a,b 85±55a 373±155b
IL-4 39±30a,b 6±5a 42±22b
IL-52 129±45a 31±15b 106±42a
IL-63 217±116 oLOD 158±110
IL-10 535±242 252±287 588±165
IL-12 p70 106±111 oLOD 75±77
IL-134 61±58 oLOD 55±39
GM-CSF 41±43 oLOD 31±28
IFNg5 77±66 19±9 75±54
TNFa4 66±80 oLOD 57±59
Abbreviations: GM-CSF, granulocyte-macrophage colony stimulating
factor; IFNg, interferon gamma; IL, interleukin; LOD, limit of detection;
TNFa, tumour necrosis factor alpha. Results are presented as means±s.d.
Means between groups were tested with one-way ANOVA using Tukey
post hoc test. Means in a row with different letters are significantly different
(Po0.05). 1N¼ 3 in the DS group. 2N¼ 4 in the DS group. 3N¼ 2 in the
sham group. 4N¼ 4 in the SGþDS group. 5N¼ 2 in the DS group.
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loss, the effects by the two procedures on lipid metabolism
inﬂammatory markers were different. Compared to DS, SGþDS rats
had a reduced faecal output of triacylglycerol and an increased
accumulation of triacylglycerol in liver that might lead to liver
damage over time. Further investigations of lipid metabolism and the
possible liver effects after SGþDS in patients should be considered.
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